Loss of MALS-1 function suppresses the mitochondrial and axon degeneration phenotypes that are caused by loss of RBM-26 function. حسب Tamjid A. Chowdhury (14149846)

"…Asterisks indicate statistically significant difference relative to wild type, Student’s <i>t</i> test (*<i>p</i> < 0.05). …"

Overexpression of MALS-1 reduces mitochondria in the PLM axon and causes axon degeneration and axon overlap defects. حسب Tamjid A. Chowdhury (14149846)

"…Asterisks in panels D and E indicate statistically significant difference relative to wild type, Z-test for proportions (***<i>p</i> < 0.0001). …"

Loss of RBM-26 causes mitochondria dysfunction in PLM. حسب Tamjid A. Chowdhury (14149846)

RBM-26 is expressed in the PLM and functions within neurons to protect against axon degeneration and prevent axon overlap defects. حسب Tamjid A. Chowdhury (14149846)

Mutations in <i>rbm-26</i> cause axon degeneration and axon overlap defects. حسب Tamjid A. Chowdhury (14149846)

Summary of Biomarker Expression in Benign Samples. The STT and LTT groups exhibit significant changes in biomarker expression compared to the nontreatment group, measured on a two-... حسب Jinho Lee (587173)

الموضوعات:

Proportion of stillbirths in Stockholm among twin and singleton pregnancies. حسب Matilda Varli Hjärne (22766125)

Loss of RBM-26 function causes a reduction in the density of mitochondria in the PLM axon. حسب Tamjid A. Chowdhury (14149846)

HBV RNaseH inhibitors effects on capsid accumulation occur independent of HBV DNA synthesis. حسب Daniel P. Bradley (10306893)

Expression of RBM-26 is disrupted by P80L and L13V missense mutations. حسب Tamjid A. Chowdhury (14149846)

Effects of 1466 on capsid and pgRNA encapsidation compared to known CAM-A and CAM-E inhibitors. حسب Daniel P. Bradley (10306893)

Screening HBV RNaseH inhibitors in HepDES19 cell for effects on capsids and core protein. حسب Daniel P. Bradley (10306893)

1466 inhibits capsid accumulation independent of HBV replication. حسب Daniel P. Bradley (10306893)

Differences among the classes of CAMs. حسب Daniel P. Bradley (10306893)

"…Some <i>N</i>-hydroxypyridinedione (HPD) HBV RNaseH inhibitors significantly reduced accumulation of capsids in HBV-replicating cells. …"

Changes in the genotypes of <i>NLRP1</i>, <i>NLRP3</i>, and <i>NLRP4</i>. حسب Hao Deng (409186)

الموضوعات:

Change in the genotypes of <i>ATM</i>, <i>ERCC1</i>, and <i>XRCC1</i>. حسب Hao Deng (409186)

الموضوعات:

Effect of the interaction of drinking, smoking and <i>ERCC1</i> rs3212986 on workers exposed to coal dust. حسب Hao Deng (409186)

الموضوعات:

Regression model analysis of the influence of <i>ERCC1</i> rs3212986 on CWP. حسب Hao Deng (409186)

الموضوعات:

Pathways analysis of ERCC1 based on CWP metabolome and proteome. حسب Hao Deng (409186)

الموضوعات:

Analysis of basic clinical data of the study population (± s). حسب Hao Deng (409186)

الموضوعات: